A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—To assess efficacy and tolerability of insulin detemir or NPH insulin added to oral therapy for type 2 diabetes in a treat-to-target titration protocol. RESEARCH DESIGN AND METHODS—Individuals (n = 476) with HbA1c (A1C) 7.5–10.0% were randomized to addition of twice-daily insulin detemir or NPH insulin in a parallel-group, multicenter trial. Over 24 weeks, insulin doses were titrated toward prebreakfast and predinner plasma glucose targets of ≤6.0 mmol/l (≤108 mg/dl). Outcomes assessed included A1C, percentage achieving A1C ≤7.0%, risk of hypoglycemia, and body weight. RESULTS—At 24 weeks, A1C had decreased by 1.8 and 1.9% (from 8.6 to 6.8 and from 8.5 to 6.6%) for detemir and NPH, respectively (NS). In both groups, 70% of participants achieved an A1C ≤7.0%, but the proportion achieving this without hypoglycemia was higher with insulin detemir than with NPH insulin (26 vs. 16%, P = 0.008). Compared with NPH insulin, the risk for all hypoglycemia with insulin detemir was reduced by 47% (P < 0.001) and nocturnal hypoglycemia by 55% (P < 0.001). Mean weight gain was 1.2 kg with insulin detemir and 2.8 kg with NPH insulin (P < 0.001), and the difference in baseline-adjusted final weight was −1.58 (P < 0.001). CONCLUSIONS—Addition of basal insulin to oral drug therapy in people with suboptimal control of type 2 diabetes achieves guideline-recommended A1C values in most people with aggressive titration. Insulin detemir compared with NPH insulin achieves this with reduced hypoglycemia and less weight gain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in A1C from triple therapy was greater at 6 months than that of conventional therapy and the superiority was maintained at 3 years.1061”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1061]
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461
Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes
Koro, C. E., Bowlin, S. J., Bourgeois, N., & Fedder, D. O. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.17 · Cited by 648
Research works printed but not linked: 1
- Raslova K, Bogoev M, Raz I, Leth G, Gall MA, Hancu N: Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes Diabetes Res Clin Pract 66:193–201, 2004 · DOI · Paper page
Cited by
Items 501–600 of 627
A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
Zinman, B., Philis‐Tsimikas, A., Cariou, B., Handelsman, Y., Rodbard, H. W., Johansen, T., Endahl, L. A., & Mathieu, C. (2012) · Cited by 2
Is Weight Gain an Unavoidable Consequence of Insulin Therapy?
(2007) · The Internet Journal of Internal Medicine · doi:10.5580/1cb5 · Cited by 2
Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2007) · Der Diabetologe · doi:10.1007/s11428-007-0132-4 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus
Bailey, C. J., & Davies, M. J. (2011) · doi:10.1093/med/9780199235292.003.1373 · Cited by 4
Self-citation(SFD), U. P. D. P. P. P. L. S. F. D. D. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70660-0 · Cited by 2
Insulin detemir: A new option for the treatment of diabetes
Funnell, M. M. (2007) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2007.00258.x · Cited by 2
Long-Acting Insulin Analogs Versus Human Insulins
Garg, S. K., & Naik, R. G. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0071 · Cited by 2
Our evolving understanding of getting to goal using insulin in type 2 diabetes
LeRoith, D. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(07)80008-9 · Cited by 2
VersorgungsLeitlinie, N. (2011) · Cited by 2
Andersen, J. T., & Sandlie, I. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch4 · Cited by 1
Commercially Available Injectables in Diabetes – Insulin, Incretins, and More
Kesavadev, J., Kalra, S., John, M., Unnikrishnan, A., Joshi, S., Sankar, P., Kumar, A., Jothydev, K., & Basanth, A. (2023) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_29_23 · Cited by 3
Soto-González, A., & Bellido, D. (2013) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-2-20 · Cited by 1
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_19 · Cited by 2
Prada, M. R., Alvis‐Guzmán, N., Bejarano, D. C., & Benavides, E. K. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Centro de Investigaciones en Economía, G. Y. T. E. S., Prada, M. R., Alvis‐Guzmán, N., de Cartagena, U., Chávez, D., Centro de Investigaciones en Economía, G. Y. T. E. S., Karpf, E., & Centro de Investigaciones en Economía, G. Y. T. E. S. (2014) · Salud Uninorte · doi:10.14482/sun.30.2.4720 · Cited by 1
Narita, T., Goto, T., Suganuma, Y., Hosoba, M., Morii, T., Sato, T. K., Fujita, H., Miura, T., Shimotomai, T., Yamada, Y., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00062.x · Cited by 1
Pashkova, E. Y. (2013) · Problems of Endocrinology · doi:10.14341/probl201359450-55 · Cited by 1
Gong, W. C. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.10.1299 · Cited by 1
Tip 2 diabetes mellitusta insülin tedavisi
ATMACA, M. H. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s1.009 · Cited by 1
Namba, M., Kaku, K., Yoshioka, N., Yamada, Y., Watada, H., Ueki, K., Terauchi, Y., Tobe, K., Araki, E., Shuto, Y., et al. (2011) · Diabetology International · doi:10.1007/s13340-011-0051-x · Cited by 1
Shaefer, C. F. (2008) · Insulin · doi:10.1016/s1557-0843(08)80028-0 · Cited by 1
Optimizing insulin therapy to individual need in type 2 diabetes
Hamson, K. (2012) · Practice Nursing · doi:10.12968/pnur.2012.23.1.33 · Cited by 1
Latif, Z. A., Pathan, M. F., Siddiqui, M. N. I., Mannan, M., Ashrafuzzaman, S., Rahman, M. M., & Sobhan, M. J. (2013) · BIRDEM Medical Journal · doi:10.3329/birdem.v3i1.17121 · Cited by 1
The Many Faces of Type 2 Diabetes
Flood, T. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2190 · Cited by 1
Kemp, T. (2010) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Diabetes Treatment: Insulin and Incretins
Fowler, M. J. (2010) · Clinical Diabetes · doi:10.2337/diaclin.28.4.177 · Cited by 1
Wainstein, J., Leibovitz, E., Segal, T., & Gavish, D. (2011) · PubMed · Cited by 1
Detemir en diabetes mellitus tipo 2
Castelán, G. P., & Sosa-Caballero, A. (2009) · Acta Médica Grupo Ángeles · Cited by 1
Son los nuevos análogos de insulina superiores a las viejas insulinas rápida y NPH
Garber, I. L. (2009) · Revista de Endocrinología y Nutrición · Cited by 1
How insulin analogues can benefit patients
Dokken, B. B. (2013) · The Nurse Practitioner · doi:10.1097/01.npr.0000425828.67564.10 · Cited by 1
Ruyatkina, L. A., & Sorokin, M. Y. (2016) · Diabetes Mellitus · doi:10.14341/dm2004150-55 · Cited by 1
Early Insulin Initiation—A Review of the Literature and Case Studies
(2012) · The Internet Journal of Family Practice · doi:10.5580/2a69 · Cited by 1
Basal-Bolus療法を実施中の糖尿病患者を対象としたインスリン デテミルの夜間QOLおよび治療満足度に関する検討
均, 石., 岩本安彦, 浩平, 加., 隆造, 河., 正, 小., & 尚子, 田. (2009) · 糖尿病 · doi:10.11213/tonyobyo.52.691 · Cited by 1
Sharma, S. K., Ajmani, A., Khosla, P., Mukhopadhyay, P., Bhatia, G., Prakash, K. G., Chhaya, G., Supe, P. D., Pavithran, V., Bora, H., et al. (2018) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2018.88016 · Cited by 2
Insulin therapy in patients with type 2 diabetes mellitus
Odeniyi, I. A., Olopade, O. B., & Fasanmade, O. A. (2019) · Journal of Clinical Sciences · doi:10.4103/jcls.jcls_5_18 · Cited by 3
Antidiabetikum-hatékonyság és -biztonság időskorban
Domboróczki, Z. (2017) · Diabetologia Hungarica · doi:10.24121/dh.2017.31 · Cited by 1
Itoh, M., Suzuki, A., Katoh, T., Sawai, Y., Asano, S., Imamura, S., Hayashi, Y., Goto, S., Takahashi, N., & Kawabe, T. (2021) · PubMed Central · doi:10.20407/fmj.2019-023 · Cited by 1
Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results
Battelino, T., & Mauricio, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01143-6 · Cited by 1
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_22 · Cited by 2
Wolters, J., Wollenhaupt, D., Aziz, M. S. A. E., & Nauck, M. A. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4758042 · Cited by 1
Stellenwert von Langzeit-Insulin-Analoga in der Therapie des Diabetes mellitus Typ 2
Ludvik, B. H., Brath, H., Wascher, T. C., & Toplak, H. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1209-4 · Cited by 2
Vangoitsenhoven, R., Narendran, P., & Mathieu, C. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch31 · Cited by 1
Cai, X., Luo, Y., Han, X., & Ji, L. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131186 · Cited by 1
Formen der Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0886-1 · Cited by 1
Insulin treatment of Type 2 diabetes: a clinical perspective
Bloomgarden, Z. T., Drexler, A., & Handelsman, Y. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00073.x · Cited by 1
Carranza, F. H., Mira, S. A., & Gonzlez, G. H. (2007) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(07)74759-8 · Cited by 1
Papel de las nuevas insulinas en el tratamiento de la diabetes
Gil, A. L., & Gutiérrez, P. C. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.10.009 · Cited by 1
Sánchez, O., & Ruiz, J. S. (2007) · Revista Clínica Española · doi:10.1157/13108763 · Cited by 1
Focus on glycaemic management: A veritable feast or a dog's dinner?
Davies, M. J. (2008) · The British Journal of Diabetes · doi:10.1177/1474651408094886 · Cited by 1
Self-citationThomsen, M. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_27 · Cited by 1
Combination Therapy for Treatment of Type 2 Diabetes
McCall, A. L. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-16 · Cited by 1
Diabetic Coma: Current Therapy of Diabetic Ketoacidosis and Non-Ketoacidotic Hyperosmolar Coma
Hensen, J. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-18 · Cited by 1
How to use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies
Aloi, J., & McCall, A. L. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch31
Cornell, S. A. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1018798
Juurinen, L. (2014) · Työväentutkimus Vuosikirja
Garabeli, A. A. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Análogos de insulina: relevancia clínica y perspectivas futuras
Roncancio, J. J. B., Labarca, J. C. A., & Naranjo, A. L. V. (2012) · Revista de la Facultad de Medicina · Cited by 2
Ampudia‐Blasco, F. J. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.10.001 · Cited by 2
Tratamiento de la diabetes mellitus tipo 2 con insulina
Izquierdo, E. S., Malpartida, K. G., & Hernández‐Mijares, A. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)76263-6 · Cited by 2
The Fallacy of Hindsight: Response to Moses and Koenen
Holleman, F., & DeVries, J. H. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0137
Shestakova, M. V., & Ballan, A. (2010) · Diabetes Mellitus · doi:10.14341/2072-0351-6023
Boudiba, A., Belhadj, M., Roula, D., & Zinaï, S. (2013) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(13)70604-7 · Cited by 1
Welches lang wirksame Insulin passt am besten?
Liebl, A. (2015) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-015-2977-6
The 3 R’s of Managing Seniors with Type 2 Diabetes: Recognition, Risks, and Remedies
Meece, J. D., Drab, S. R., Drab, S. R., Meece, J. D., Meece, J. D., Garza, H., & Garza, H. (2009) · The Consultant Pharmacist · doi:10.4140/tcp.sb.2009.002
Ampudia‐Blasco, F. J. (2012) · Avances en Diabetología · doi:10.1016/s1134-3230(12)70018-2
Tratamiento de la diabetes: insulinoterapia
Lucas, E. G., Rey, V. R., Gutiérrez, J. M. Á., & García, J. J. L. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70431-6
Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point?
Shaefer, C. F. (2007) · Insulin · doi:10.1016/s1557-0843(07)80038-8
Recent advances with insulin degludec for the treatment of Type 2 diabetes
Stokes, V. J., & Gough, S. C. L. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.917045
Insulin detemir: a long-acting insulin analog for the treatment of Type 1 and 2 diabetes
Meneghini, L. (2008) · Therapy · doi:10.2217/14750708.5.4.513
Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes
Shaefer, C. F. (2008) · Insulin · doi:10.1016/s1557-0843(08)80033-4
Home, P., Shen, C., Hasan, M. I., Latif, Z. A., Chen, J.-W., & González-Gálvez, G. (2014) · Diabetes Care · doi:10.2337/dc14-1098
Self-citationHamson, K. (2012) · Independent Nurse · doi:10.12968/indn.2012.21.5.91915
Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
Roden, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61152-6
Berbovaia, N. I. (2010) · Problems of Endocrinology · doi:10.14341/probl201056264-71
Prise de poids et traitements antidiabétiques
Vergès, B. L. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)74896-x · Cited by 1
Intensive Glucose Control in Elderly Adults—Reply
Abrahamson, M. J. (2007) · JAMA · doi:10.1001/jama.297.20.2196
Insulinothérapie dans le diabète de type 2
Hartemann, A. (2007) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(07)92000-3
Siegmund, T. (2007) · Notfall & Hausarztmedizin (Notfallmedizin) · doi:10.1055/s-2007-977652
Sánchez, O., & Ruiz, J. S. (2008) · Medicina Clínica · doi:10.1157/13116324 · Cited by 1
Evaluating The Therapeutic Package for Diabetic Patients: The Whole Exceeds the Sum of Its Parts
Leichter, S. B. (2006) · Clinical Diabetes · doi:10.2337/diaclin.24.3.102
Insulin therapy in type 2 diabetes patients : balancing between evidence and experience
van Avendonk, M. J. P. (2010) · Utrecht University Repository (Utrecht University)
Dzida, G. J., & Tarnowska, I. (2009) · Clinical Diabetology
Insulin Therapy in Home Health: A Review
Hess, R., & Odle, B. L. (2012) · Home Health Care Management & Practice · doi:10.1177/1084822312458106
Recombinant Insulin in Type 2 Diabetes Treatment: Where Are We Now?
Russo, G. T., Villari, P., Romeo, E. L., Giandalia, A., & Cucinotta, D. (2012) · Science Journal of Clinical Medicine · doi:10.11648/j.sjcm.20120101.12
Understanding the safety of the new ultra long acting basal insulin.
Ramachandran, A., Gupta, V., Kesavadev, J., & Kalra, S. (2014) · PubMed
Niswender, K. (2009) · Clinical Diabetology
Initiating and titrating insulin in patients with type 2 diabetes
Henske, J. A., Griffith, M. L., & Fowler, M. J. (2010) · Clinical Diabetology
Clinical Use of New Insulins and New Insulin Delivery Systems
Lim, T., & Ko, S. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.4.242
Diabetische Notfallsituationen – die Hypoglykämie
Siegmund, T., & Schumm‐Draeger, P. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1264-y
Von einfach bis flexibel — zur Auswahl stehen drei Strategien: Insulintherapie bei Typ-2-Diabetes
Liebl, A. (2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-1298-2
Insulin Treatment in Managing Type 2 Diabetes: Challenges and Opportunities
Leahy, J. L. (2007) · JAAPA · doi:10.1097/01720610-200710000-00007
Insulinothérapie dans le diabète de type2
Molines, L., Darmon, P., Jannot-Lamotte, M.-F., Schaepelynck, P., Tréglia, C., & Raccah, D. (2013) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(13)56365-7
Achieving fasting and postprandial blood glucose control in type 2 diabetes
Robertson, D. (2006) · British Journal of Hospital Medicine · doi:10.12968/hmed.2006.67.10.22057
Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tip Dergisi
Okuyucu, A., Bedir, A., Özmen, Z. C., & Biyokimya, T. D. H. (2012)
Insulin treatment in type 2 diabetes
Arnedo, J. A., & Tejedor, J. L. (2008)
Update of the evidence-based guideline of the German Diabetes Association
Matthaei, S., Bierwirth, R., Fritsche, A., Häring, U., Kellerer, M., Kunt, T., Schernthaner, G., Siegel, E. G., & Thienel, F. (2008)
Das Spektrum der Möglichkeiten wächst: Insulintherapie bei Typ-2-Diabetes heute
Siegmund, T., & Schumm‐Draeger, P. (2013) · Info Diabetologie · doi:10.1007/s15034-013-0387-3
Utilização de insulina para tratamento de diabetes no Brasil
Vieira, P. F. C. (2016) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2016.04.d.21276
Metadata
- Authors
- Hermansen, K., Davies, M., Derezinski, T., Martinez Ravn, G., Clauson, P., Home, P., & on behalf of the Levemir Treat-to-Target Study Group
- Affiliations
- Aarhus University Hospital (DK)
- Leicester Royal Infirmary (GB)
- Out-Patient Clinic, NZOZ Eskulap, Gniewkowo, Poland
- Out-Patient Clinic, Novo Nordisk, Bagsværd, Denmark
- Novo Nordisk (Denmark) (DK)
- Newcastle University (GB)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-06-01
- Volume
- 29
- Issue
- 6
- Pages
- 1269-1274
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2149194615
- Cited by
- 627
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 13 · 2019: 11 · 2018: 16 · 2017: 15 · 2016: 24 · 2015: 31 · 2014: 44 · 2013: 59 · 2012: 55
- FWCI
- 48.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin detemir, NPH insulin, basal insulin, type 2 diabetes, insulin-naive patients, oral glucose-lowering agents, adjunctive therapy, glycemic control, HbA1c, hypoglycemia, nocturnal hypoglycemia, weight gain
- MeSH terms
- Insulin Detemir, Administration, Oral, Adult, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin, Isophane, Weight Gain, Body Mass Index, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.